GLUE Operating Expenses

Monte Rosa Therapeutics Inc · Operating Expenses

GLUE logo

GLUE Operating Expenses

Latest reported$58.10M
GLUE Quarterly Operating Expenses ($4.29M → $58.10M)
High-resolution chart · PNG

GLUE operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
58,098,000
52,215,000
52,496,000
45,743,000
38,748,000
40,893,000
47,643,000
35,743,000
35,277,000
34,114,000
34,863,000
36,968,000
37,221,000
34,259,000
32,489,000
28,362,000
27,231,000
24,302,000
23,387,000
19,868,000
18,123,000
11,504,000
11,936,000
6,386,000
5,396,000
4,293,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.